Vimarsana
Biggest News Aggregation in the World

Page 18 - Accessed August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed August Today - Breaking & Trending Today

AbbVie Submits Regulatory Applications to FDA and EMA for Risankizumab (SKYRIZI®) in Ulcerative Colitis - Vimarsana News

AbbVie Submits Regulatory Applications to FDA and EMA for Risankizumab (SKYRIZI®) in Ulcerative Colitis

Submissions are supported by two Phase 3 clinical trials demonstrating risankizumab achieved the primary endpoint of clinical remission and key secondary endpoints as an induction and maintenance...

What Goes Into a Valuable Dermoscopy - Vimarsana News

What Goes Into a Valuable Dermoscopy

Ashfaq Marghoob, MD, discusses his recent workshop presentation on dermoscopies for skin cancer.

THE CRUEL TRADE: AB 840 CALIFORNIA COLLEGES MOVE TO LEGALIZE ALCOHOL ADVERTISING TO UNDERAGE YOUTH - Vimarsana News

THE CRUEL TRADE: AB 840 CALIFORNIA COLLEGES MOVE TO LEGALIZE ALCOHOL ADVERTISING TO UNDERAGE YOUTH

/PRNewswire/ -- Alcohol Justice & California Alcohol Policy Alliance are asking state policy makers in Sacramento to imagine an experiment of the kind...

Medicare Limits Cancer Patients' Access to Home Infusions. A New Bill Could Change That. - Vimarsana News

Medicare Limits Cancer Patients' Access to Home Infusions. A New Bill Could Change That.

The Preserving Patient Access to Home Infusion Act could make home infusions more accessible, particularly for patients with cancer.

Exelixis Announces Positive Results from Phase 3 CABINET Pivotal Trial Evaluating Cabozantinib in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors - Vimarsana News

Exelixis Announces Positive Results from Phase 3 CABINET Pivotal Trial Evaluating Cabozantinib in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors

– CABINET trial will be unblinded and stopped early due to a dramatic improvement in efficacy per a unanimous recommendation by The Alliance for Clinical Trials in Oncology independent Data and...